Yubal, Dasch H.
HRN: 18-91-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/22/2023
10/29/2023
IV
160mg
TID
Dengue Fever W/ WS; UTI
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes